πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,022 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7781584

Dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7781175

Method of screening compounds which alter the binding properties of GPR39, and homologs th

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7777047

Indole compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7767665

1,3-benzothiazinone derivatives and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 03 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7763716

Antibody against NPW

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7754856

Human sodium-dependent bile acid transporter proteins

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7754220

Methods of inhibiting secretion of follicle-stimulating hormone and testosterone

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7750037

Antidepressant

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7745623

Cyclic amide derivative, and its production and use

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7737282

Benzimidazole compound crystal

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 15 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7732626

Fused cyclic compounds

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7732446

Dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7723496

Preventives/remedies for cancer

Takeda Pharmaceutical Company Limited Β· Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7718798

Indole compound

Takeda Pharmaceutical Company Limited Β· Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7714009

Nitrogen-containing fused heterocyclic compounds

Takeda Pharmaceutical Company Limited Β· Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7713973

Kinase inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7700361

Secretory or membrane protein expressed in skeletal muscles

Takeda Pharmaceutical Company Limited Β· Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7700128

Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxye

Takeda Pharmaceutical Company Limited Β· Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7687625

Dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7671174

Ligand to GPR8

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7662380

ZAQ ligand-1 antibodies and uses thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7662974

Process for producing fused imidazole compound, reformatsky reagent in stable form, and pr

Takeda Pharmaceutical Company Limited Β· Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7662408

Sustained-release preparations

Takeda Pharmaceutical Company Limited Β· Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7659267

1,3-Benzothiazinone derivatives, process for producing the same use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted